Table 5.
Additional features of placebo control design and implementation.
| Feature | Reported in | ||
|---|---|---|---|
| n | % | ||
| (Mis)informing patients that only efficacious treatments are investigated | 32 | 16.2 | |
| Deliberately enhancing patients' expectations of therapeutic benefit (other means) | 16 | 8.1 | |
| Only enrolling treatment-naïve patients | 30 | 15.2 | |
| Enhancing control provider expectations of therapeutic benefit | 9 | 4.8 | Not applicable in 10 automated interventions (n = 189) |
| Providing specific training to the therapists to deliver the control intervention | 43 | 22.8 | Not applicable in 10 automated interventions (n = 189) |
Total n = 178, unless otherwise indicated. Note that the provided assessments are dependent on author reporting.